US 7727534
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
granted A61KA61K35/28A61K35/765
Quick answer
US patent 7727534 (Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions) held by ONCOLYTICS BIOTECH INC. expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/28, A61K35/765, A61K48/00, A61P